Interview #13 as we prepare for the 6th edition of Doctors 2.0 & You, is with Nathalie Jullian from Ipsen. Here we broach a new topic in digital health: how a collaborative digital platform, built with an external partner ;-), Dassault Systems, is enabling pharma to make its research and development more inclusive on both the inside and the outside.
Shouldn't all functions be able to collaborate in this way, as society becomes more participatory and boundaries diminish?
Nathalie Jullian, 2016 speaker at Doctors 2.0 & You will share the details of how this new platform came into being on May 26 in Paris. And we thank her for taking the time to do the following interview.
Q1. Let’s learn more about you professionally, Nathalie. You have some very specialized professional experience:
I started my career as a software engineer in the pharmaceutical industry, developing tools for the visualization of 2D and 3D protein structures. After a couple of years, I went back to university and started my PhD at the School of Pharmacy in molecular & structural chemistry, which is all about understanding the relationships between structure and activity. I have been working in that field since then, and there is still a lot to do and to learn.
Q2. At Ipsen you are heading up a collaborative R&D platform. What can you tell us about this platform? Are you aiming for a better collaboration both within Ipsen and between Ipsen and outside experts?
As you know Ipsen is in the middle of a digital transformation strategy. And I am co-leading a project for the implementation of a new collaborative platform for our R&D scientists. The project aims at providing an open and interactive tool to facilitate data sharing and to help navigate through internal proprietary data and public data. One component of the project is a collaborative agreement with Dassault Systèmes, the European multinational software company, and the development of new innovative tools around their 3D Experience platform. Our objectives are to improve internal processes, to support data-driven decision making and thus to accelerate Ipsen performance for the delivery of new therapeutic solutions.
Facilitating collaboration is obviously at the heart of the project, and we mean collaboration with Dassault Systèmes, within Ipsen (between countries, across business areas) and with our external partners.
Q3. Do you think collaboration in R&D is the next big trend for pharma?
Moving a drug project forward from research toward development and ultimately to the market has always been a collaborative journey. Many different departments are involved along the process ,and seamless collaboration is a key element for success.
In the past years, we meant collaboration within the company, while the ecosystem is evolving now with the incorporation of academic experts, biotech companies and other pharmaceutical partners. Also, new collaboration models are emerging with quite a few public private partnerships such as the IMI projects in Europe for example (Innovative Medicine Initiative).
We strongly believe that key collaborations will drive future success in our industry.
Q4. Are you a geek and whether you are or are not, which apps do you use most often, professionally and personally?
I do not picture myself as a “geek”, although I am familiar with quite a few apps. Having worked with different companies and in various countries, I like LinkedIn as it allows me to keep in touch with my former colleagues. I spend all of my working hours in front of a computer, so of course I do use many business oriented applications, mostly in the Drug Discovery area.
Q5. You found out about Doctors 2.0 & You through the Ipsen partnership I believe. What made you excited about participating and what will you be presenting?
It is a great opportunity to discuss with a different audience, and to present some aspects of the changes that are on-going in the pharmaceutical R&D area.
Photo below of a design workshop at Doctors 2.0 & You shows international participants learning in collaboration about "empathy" for design
See you all soon at Doctors 2.0 & You May 26-27, 2016.